19352-02-4 Usage
Uses
Used in Pharmaceutical Industry:
1-(naphthalen-1-yl)propan-2-amine is used as a psychoactive substance for its stimulant effects, which can be exploited for various pharmaceutical applications. However, it is important to note that its use is regulated due to its potential for abuse and associated health risks.
Used in Research and Development:
In the field of research and development, 1-(naphthalen-1-yl)propan-2-amine can be used as a compound for studying the effects of substituted amphetamines on the human body. This can contribute to the development of new drugs with similar properties but with reduced side effects and lower potential for abuse.
Used in Recreational Drug Market (with caution):
1-(naphthalen-1-yl)propan-2-amine is used as a recreational drug for its stimulant and psychoactive effects. However, its use in this context is controversial and illegal in many jurisdictions due to the associated health risks and potential for addiction.
It is crucial to emphasize that the use of 1-(naphthalen-1-yl)propan-2-amine in any context should be approached with caution and under strict regulation, given its classification as a controlled substance and the potential for adverse health effects.
Check Digit Verification of cas no
The CAS Registry Mumber 19352-02-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,3,5 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 19352-02:
(7*1)+(6*9)+(5*3)+(4*5)+(3*2)+(2*0)+(1*2)=104
104 % 10 = 4
So 19352-02-4 is a valid CAS Registry Number.
19352-02-4Relevant academic research and scientific papers
Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors
Vilches-Herrera, Marcelo,Miranda-Sepulveda, Juan,Rebolledo-Fuentes, Marco,Fierro, Angelica,Luehr, Susan,Iturriaga-Vasquez, Patricio,Cassels, Bruce K.,Reyes-Parada, Miguel
experimental part, p. 2452 - 2460 (2009/09/08)
A series of naphthylisopropylamine and N-benzyl-4-methylthioamphetamine derivatives were evaluated as monoamine oxidase inhibitors. Their potencies were compared with those of a series of amphetamine derivatives, to test if the increase of electron richness of the aromatic ring and overall size of the molecule might improve their potency as enzyme inhibitors. Molecular dockings were performed to gain insight regarding the binding mode of these inhibitors and rationalize their different potencies. In the case of naphthylisopropylamine derivatives, the increased electron-donating capacity and size of the aromatic moiety resulting from replacement of the phenyl ring of amphetamine derivatives by a naphthalene system resulted in more potent compounds. In the other case, extension of the arylisopropylamine molecule by N-benzylation of the amino group led to a decrease in potency as monoamine oxidase inhibitors.